- Home
- LEGN vs CROX Comparison
LEGN vs CROX Comparison
Compare LEGN & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | CROX |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.1B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | LEGN | CROX |
|---|---|---|
| Price | $24.92 | $111.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 12 |
| Target Price | $63.08 | ★ $98.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,040,647,000.00 |
| Revenue This Year | $42.68 | $1.89 |
| Revenue Next Year | $30.52 | $2.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.24 | $73.21 |
| 52 Week High | $45.30 | $116.11 |
Technical Indicators
Market Signals| Indicator | LEGN | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 78.54 | 81.40 |
| Support Level | $17.01 | $74.96 |
| Resistance Level | $28.97 | N/A |
| Average True Range (ATR) | 1.21 | 4.03 |
| MACD | 0.63 | 2.18 |
| Stochastic Oscillator | 79.40 | 99.36 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.